XERS
Xeris Pharmaceuticals Inc
9.10$
-1.8%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| – | +44.7% | +58.4% | +10.4% | +0.0% | +1,721.8% | +122.3% | +48.7% | +23.9% | +43.7% | |
| – | -50.0% | +950.0% | +3,716.7% | +0.0% | +730.8% | +70.0% | +26.6% | +28.6% | +45.0% | |
| – | +45.5% | +56.1% | -53.8% | +0.0% | +3,141.5% | +141.5% | +54.4% | +22.9% | +43.4% | |
| – | +97.0% | +101.6% | +48.7% | +0.0% | -58.4% | -16.7% | +6.6% | +14.4% | +21.9% | |
| – | +97.4% | +163.4% | +198.7% | +16.9% | +70.5% | +9.6% | +6.1% | +11.9% | +11.6% | |
| – | +97.1% | +119.2% | +99.9% | +0.0% | +22.6% | +12.0% | +5.7% | +11.5% | +6.8% | |
| – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +127,150.0% | +181.5% | +0.0% | +0.2% | +96.4% | +88.7% | +24.7% | -12.3% | |
| – | – | – | – | – | – | – | – | – | – | |
| – | – | +180,800.0% | -125.3% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.